生命科学资讯

Sarepta CEO Doug Ingram to step down

Trump’s State of the Union trumpets healthcare greatest hits, but no new policies

Gilead, Merck plan to debut new daily HIV pills

Make way, Camzyos: Cytokinetics touts promising early launch for rival heart drug

LUMI-lab: A foundation model-driven autonomous platform enabling discovery of ionizable lipid designs for mRNA delivery

Editing strigolactone hormone receptor for robust antiviral silencing in rice

A regulatory network promotes apoplastic alkalinization to prime plant immunity in tissues distal to site of infection

Fungal-derived cellobiose metabolic pathway fuels T cells to bypass intratumoral glucose competition

ARPA-H designates up to $144M for anti-aging medical research

Worried Trump's MFN push will ‘destroy biotech innovation,’ midsize companies form coalition to fight back

Charles River sells manufacturing and discovery businesses to fulfill promised pivot

Appointments and advancements for Feb. 25, 2026

Financings for Feb. 25, 2026

In the clinic for Feb. 25, 2026

Other news to note for Feb. 25, 2026

Regulatory actions for Feb. 25, 2026

Alkermes’ Richard Pops to step down after three-decade run as CEO

Charles River sells its CDMO and European discovery businesses

Novo Nordisk inks $2.1B pact with Langer startup to boost oral drug delivery prowess

After gene therapy exit, Pfizer locks in global license for Beam gene editing candidate